Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. NUS
  6. >
  7. Earnings
stocks logo

NUS Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of NU Skin Enterprises Inc(NUS) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of NU Skin Enterprises Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-06After Hours0.300.34+13.33364.20M364.21M--15.79-11.36
FY2025Q22025-08-07After Hours0.250.43+72.00386.10M386.14M+0.01+8.90+40.73
-2025-05-08After Hours0.150.23+53.33399.80M364.49M-8.83+11.04+18.83
FY2024Q42025-02-13After Hours0.230.38+65.22436.05M445.55M+2.18+17.76+18.38
FY2024Q22024-08-08After Hours0.180.21+16.67431.87M439.08M+1.67-3.17-5.10
FY2024Q12024-05-08-0.050.09+80.00432.35M417.31M-3.48+1.39+13.39
FY2023Q42024-02-14-0.290.37+27.59476.39M488.64M+2.57+0.23-27.20
FY2023Q32023-11-01-0.640.56-12.50520.09M498.77M-4.10-1.95-9.32
FY2023Q22023-08-01-0.530.54+1.89509.30M500.26M-1.77+1.19-9.39
-2023-05-03-0.330.37+12.12----0.35-5.49
AI Stock Picker
AI Stock Picker

NUS Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, NU Skin Enterprises Inc reported performance for FY2025Q3, announced on 2025-11-06. The company achieved an EPS of 0.34, compared to analyst estimates of 0.30 by 13.33% . Revenue for the quarter reached 364.21M compared to expectations of 364.20M by 0.00% .
The stock price reacted with a -15.79% one-day change and a -11.36% five-day change following the earnings release. These movements reflect market reaction in NU Skin Enterprises Inc growth trajectory and strategic initiatives.

NUS Earnings Forecast

Looking ahead, NU Skin Enterprises Inc(NUS) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 382.70M and an EPS of 0.30.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q4 2025, revenue estimates have been adjusted No Change by 0% . These revisions correlate with a -14.62% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in NU Skin Enterprises Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between NUS's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Revenue Estimates for Q4 2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-14.62%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:1.50B
--
EPS Estimate-Annual FY 2025:1.30
—
Stock Price9.81
Financial AI Agent
Financial AI Agent

NUS Revenue and EPS Performance: A Historical Perspective

NU Skin Enterprises Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-06,After Hours):
EPS: 0.34 (Actual) vs.0.30 (Estimate) (13.33%)
Revenue: 364.21M (Actual) vs. 364.20M (Estimate) (0.00%)
Price Reaction: -15.79%(1-Day), -11.36%(5-Day)
FY2025Q2 (2025-08-07,After Hours):
EPS: 0.43 (Actual) vs.0.25 (Estimate) (72.00%)
Revenue: 386.14M (Actual) vs. 386.10M (Estimate) (0.01%)
Price Reaction: 8.90%(1-Day), 40.73%(5-Day)
(2025-05-08,After Hours):
EPS: 0.23 (Actual) vs.0.15 (Estimate) (53.33%)
Revenue: 364.49M (Actual) vs. 399.80M (Estimate) (-8.83%)
Price Reaction: 11.04%(1-Day), 18.83%(5-Day)
Earnings Reaction
The chart below shows how NUS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, NUS sees a +2.98% change in stock price 10 days leading up to the earnings, and a +1.71% change 10 days following the report. On the earnings day itself, the stock moves by -0.36%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -15.79% on the day following the earnings release and then changed by -12.47% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Intellectia AI SwingMax
Intellectia AI SwingMax

Transcript Summary

NU Skin Enterprises Inc (NUS) Q3 2025 Earnings Call Summary
Positive
2025-11-06
The earnings call highlights strong financial performance, with EPS at the high end of guidance and improved margins. The company is expanding into India and enhancing product offerings, indicating growth potential. Despite challenges like foreign currency headwinds and supply chain issues, the strategic initiatives, especially the Prysm iO launch and market expansion, suggest a positive outlook. Shareholder returns through dividends and buybacks further support this sentiment. The Q&A section reveals cautious optimism, with management addressing market entry strategies and growth in Southeast Asia, reinforcing a positive sentiment.
NU Skin Enterprises Inc (NUS) Q2 2025 Earnings Call Summary
Positive
2025-08-07
The earnings call reveals strong financial performance with EPS significantly above guidance, improved operational efficiencies, and a strategic focus on expanding in high-growth markets like Latin America and India. Despite macroeconomic challenges in key regions, optimistic guidance and strategic initiatives like Prysm iO suggest potential growth. The absence of share repurchases is offset by dividend payments, and the company's positive cash flow signals financial health. These factors, combined with optimistic guidance and strategic market expansion, indicate a positive stock price movement in the short term.
NU Skin Enterprises Inc (NUS) Q1 2025 Earnings Call Summary
Positive
2025-05-09
The earnings call presents several positive indicators: strong revenue and EPS performance, significant growth in Latin America, and a share buyback program. The Q&A session highlights strategic initiatives and market expansion plans, though it notes macroeconomic pressures and regional challenges. Overall, the positive financial results, strategic priorities, and shareholder returns outweigh the concerns, suggesting a positive stock price movement.
NU Skin Enterprises Inc (NUS) Q1 2025 Earnings Call Summary
Neutral
2025-05-08
The earnings call presents a mixed picture: strong growth in Latin America, improved margins, and a solid cash position are positive factors. However, challenges like macroeconomic pressures, competitive pressures in the U.S. and Canada, and a decline in gross margins offset these positives. The absence of Q&A insights and significant foreign currency impacts further contribute to the neutral outlook. The dividend and share repurchase activities are positive but not substantial enough to drive a strong positive sentiment.
Nu Skin Enterprises, Inc. (NUS) Q3 2024 Earnings Call Summary
Neutral
2024-11-08
The earnings call presents mixed signals: a revenue decline and foreign currency impact are negative, but EPS improvement and operational recovery are positive. The Q&A section reveals management's cautious optimism and lack of clarity on stabilization timelines. No share repurchase and a dividend payout suggest limited shareholder returns. The overall sentiment is neutral, as positive earnings and operational improvements are offset by revenue decline and uncertain guidance.

People Also Watch

FAQ

arrow icon

What were the key highlights of NUS’s latest earnings report for FY2025Q3?

NUS reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 364.21M against an estimate of 364.20M, resulting in a 0% surprise. The EPS was 0.34, surpassing the expected 0.3 by 13.33% . The stock experienced a -15.79% price change on the earnings day and a -11.36% change over the next five days, reflecting market reactions to the results.
arrow icon

How did NUS’s stock price react after the FY2025Q3 earnings release?

Following NUS’s FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by -15.79% on the day of the release. Over the subsequent five days, it saw a -11.36% change. Historically, NUS’s stock price tends to shift by an average of +2.98% in the 10 days leading up to earnings and +1.71% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for NUS for 2025/Q4?

For 2025/Q4, analysts estimate NUS’s annual revenue to reach 382.70M, while the EPS is projected at 0.30. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does NUS’s stock price correlate with earnings forecast revisions?

The correlation between NUS’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from NUS’s next earnings report?

Based on historical trends, NUS’s stock price typically moves by +2.98% in the 10 days before its earnings and +1.71% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.30 and revenue of 382.70M.
arrow icon

What is the sentiment in NU Skin Enterprises Inc (NUS) Q3 2025 Earnings Call Summary?

The earnings call highlights strong financial performance, with EPS at the high end of guidance and improved margins. The company is expanding into India and enhancing product offerings, indicating growth potential. Despite challenges like foreign currency headwinds and supply chain issues, the strategic initiatives, especially the Prysm iO launch and market expansion, suggest a positive outlook. Shareholder returns through dividends and buybacks further support this sentiment. The Q&A section reveals cautious optimism, with management addressing market entry strategies and growth in Southeast Asia, reinforcing a positive sentiment.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free